As obesity drug stocks soared, these stocks fell too far, analysts say

While Novo Nordisk's Select study stoked confidence in the weight loss drug market, it spooked holders of medtech and liver disease stocks seen losing out.

Related Keywords

Robbie Marcus ,Imron Zafar ,Zimmer Biomet ,Sagimet Biosciences ,Philips ,Abbott Laboratories ,Deutsche Bank ,Terns Pharmaceuticals ,Madrigal Pharmaceuticals ,Goldman Sachs ,Novo Nordisk ,Intuitive Surgical ,Inspire Medical Systems ,Akero Therapeutics ,Viking Therapeutics ,